APA

Heptinstall S., Espinosa D. I., Manolopoulos P., Glenn J. R., White A. E., Johnson A., Dovlatova N., Fox S. C., May J. A., Hermann D., Magnusson O., Stefansson K., Hartman D. & Gurney M. (20081231). DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. : Platelets.

Chicago

Heptinstall Stan, Espinosa David Iyu, Manolopoulos Panagiotis, Glenn Jackie R, White Ann E, Johnson Andrew, Dovlatova Natalia, Fox Sue C, May Jane A, Hermann David, Magnusson Olafur, Stefansson Kari, Hartman Dan and Gurney Mark. 20081231. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. : Platelets.

Harvard

Heptinstall S., Espinosa D. I., Manolopoulos P., Glenn J. R., White A. E., Johnson A., Dovlatova N., Fox S. C., May J. A., Hermann D., Magnusson O., Stefansson K., Hartman D. and Gurney M. (20081231). DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. : Platelets.

MLA

Heptinstall Stan, Espinosa David Iyu, Manolopoulos Panagiotis, Glenn Jackie R, White Ann E, Johnson Andrew, Dovlatova Natalia, Fox Sue C, May Jane A, Hermann David, Magnusson Olafur, Stefansson Kari, Hartman Dan and Gurney Mark. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. : Platelets. 20081231.